Investigating the The Effect Of Evening Primrose On Blood Sugar And Lipid Profile In Pre-Diabetic Menopausal Women Referred To Rafsanjan Comprehensive Health Services Centers In 1397

Determination of the Effect of Flower Magnetic Capsule on Blood Glucose and Lipid Profile in Pre-Diabetic Postmenopausal

Through the sampling available to postmenopausal women who have the criteria for entering the study, they describe the research conditions and, if they wish, they will receive written consent. And the participants are assigned to the intervention and control groups by simple randomization method.

pre-diabetic postmenopausal women referring to comprehensive health centers in Rafsanjan.

written consent of the company in the study Pre-diabetic women Non-use of alcohol, tobacco and narcotics Lack of HRT at present Non-use of supplementary extract of Maghrib flower Women who have been at least 12 months since their last menstruation. Lack of chronic mental illness No use of blood glucose suppressants

For participating peopleFBS and HbA1C test is requested . After the results are announced, for women with FBS = 100-125, tests for HLD, LDL, TG and cholesterol are requested. Participants were randomly assigned to intervention and control groups. Each participant will receive 30 capsules (Maghreb flower or placebo) with the daily administration of 2 capsules (1000 mg / day in the morning and at night) and a daily intake form. Demographics of the participants are also collected using the form of these features. During the study, all participants will be followed up by phone every week to prevent sample loss and to ensure the correct method of use. Also, at the beginning of each month, participants will be given the following capsules by the attendees at the Comprehensive Health Center. After 3 months of taking capsules, all tests will be re-tested for all participants.

FBS , HbA1C,HDH,LDL,TG,Cholestrol

Randomization is performed in this study by simple randomization. To assign individuals to each drug and drug group, participants who have signed a consent form to participate in the study are asked to draw in one. Be divided into groups A and B.

In order to inform the participants, researcher and analyst, the pharmaceutical manufacturer (Barij Essen) will receive information about the shape, size and color of the capsule and will be asked from the placebo company (Zahrawi) to make placebo capsules in accordance with the characteristics Drug should be provided. Then, the person who is not involved in the research is asked to pack the capsules in two different types, identifying each category with letters A and B. After completing the sampling and doing the analysis, the person is asked to specify the type of each categories.

No more information